A LINC00472-encoded polypeptide impedes migration and proliferation through modulation of the HDAC2/SP1 axis in
Lei Xu1, Haoyong Kuang2, Haodong Peng2
1Department of Thoracic Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, Henan, 450003, China.
Objective:
While long non-coding RNAs (lncRNAs) are increasingly recognized as sources of functional micropeptides, their roles in non-small cell lung cancer (NSCLC) remain poorly characterized. This study investigates the therapeutic potential and molecular mechanism of LINC00472-encoded polypeptide in NSCLC.
Methods:
Through integration of ribosome profiling, transcriptomics, and co-expression analysis, we systematically identified lncRNA-encoded polypeptides in NSCLC. Translational competence was validated via ribosome affinity purification (TRAP), Western blot, and immunofluorescence (IF). Functional assays (CCK-8, EdU, wound healing, transwell) and xenograft models assessed anti-tumor effects. HDAC2/SP1 interaction dynamics were analyzed by co-IP and luciferase reporter systems.
Results:
Multi-omics screening identified LINC00472 as a bifunctional transcript encoding a 15-aa polypeptide (LINC00472-ORF). LINC00472-ORF exhibited potent tumor-suppressive activity, reducing NSCLC proliferation and motility in vitro, while suppressing xenograft growth in vivo. Mechanistically, LINC00472-ORF disrupted HDAC2/SP1 interaction, inducing SP1 hyperacetylation, cytoplasmic retention, and transcriptional inactivation of downstream oncogenic genes.
Conclusion:
We unveil LINC00472-ORF as a dual-function therapeutic agent that targets the HDAC2/SP1 axis to inhibit NSCLC progression.
Insights
Researchers discovered a small protein from the LINC00472 long non-coding RNA (lncRNA) that fights non-small cell lung cancer (NSCLC). This LINC00472-encoded polypeptide (LINC00472-ORF) shows therapeutic potential by targeting the HDAC2/SP1 pathway.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Biology
Background:
- Long non-coding RNAs (lncRNAs) are emerging as sources of functional micropeptides.
- The role of lncRNA-encoded polypeptides in non-small cell lung cancer (NSCLC) is not well understood.
Purpose of the Study:
- To investigate the therapeutic potential of a polypeptide encoded by LINC00472 in NSCLC.
- To elucidate the molecular mechanism underlying the anti-cancer effects of LINC00472-encoded polypeptide.
Main Methods:
- Integrated multi-omics (ribosome profiling, transcriptomics) to identify lncRNA-encoded polypeptides.
- Validated translational competence using ribosome affinity purification (TRAP), Western blot, and immunofluorescence.
- Assessed anti-tumor effects through in vitro functional assays and in vivo xenograft models.
- Analyzed protein interactions (HDAC2/SP1) using co-immunoprecipitation and luciferase reporter assays.
Main Results:
- Identified LINC00472 as a bifunctional transcript encoding a 15-amino acid polypeptide (LINC00472-ORF).
- LINC00472-ORF demonstrated significant tumor-suppressive activity, inhibiting NSCLC proliferation and motility in vitro and xenograft growth in vivo.
- Discovered that LINC00472-ORF disrupts the HDAC2/SP1 interaction, leading to SP1 hyperacetylation and inactivation of oncogenic gene transcription.
Conclusions:
- LINC00472-ORF acts as a dual-function therapeutic agent against NSCLC.
- The mechanism involves targeting the HDAC2/SP1 axis to suppress tumor progression.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Abnormal Proliferation
Spreading of Chromatin Modifications
Writers
The writer...
Epigenetic Regulation
X-chromosome...
Hedgehog Signaling Pathway


